Abbott announced it has received CE Mark and Health Canada approval for its Amplatzer™ Steerable Delivery Sheath, which is used with the company's market-leading Amplatzer Amulet™ Left Atrial Appendage (LAA) Occluder. Now available in Europe and Canada, the new device is the first steerable delivery sheath that has been developed specifically for minimally invasive LAA occlusion (or closure) procedures to treat patients diagnosed with atrial fibrillation who are at risk of ischemic stroke.
- Read more about Abbott Receives European and Canadian approval for Amplatzer
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/abbott-receives-european-and-canadian-approval-for-amplatzer
No comments:
Post a Comment